YOUR DEDICATED PARTNER
FOR EXPERT PHAGE DISPLAY SOLUTIONS
At Cell Origins, our leading scientists offer innovative and tailored phage display services, delivered through a boutique, one-on-one client experience focused on achieving excellent and impactful results for your research.
At Cell Origins, we stand behind every discovery. As founders, we personally commit to delivering the highest standards of scientific rigor, innovation, and service. Your success is our mission.
WE BELIEVE DISCOVERY IS PERSONAL
As a boutique contract research organization specializing in peptide and antibody discovery through phage display, we combine world-class scientific expertise with one-on-one collaboration. Every project we take on is a true partnership — tailored to your goals, fueled by precision, and driven by a shared commitment to innovation. With a flexible model and a focus on unmatched quality, we deliver solutions that larger CROs simply can't replicate.
Cell Origins was founded by scientists trained directly under the pioneers of phage display at the University of Missouri — where the technology was first developed by George Smith who later received the Nobel prize for his work. With over 40 years of combined experience, our team brings deep expertise, hands-on innovation, and a personal commitment to excellence. We offer more than technical services: we build true partnerships, working closely with each client to tailor discovery strategies that drive real results. At Cell Origins, every project is grounded in innovation — and in a shared passion for advancing the next generation of peptides and antibodies.
DECADES OF DISCOVERY. PRECISION IN EVERY PARTNERSHIP.
LIBRARIES
Premade and customized phage display libraries.
ExploreBIOPANNING
Customized strategies using our MultiTier approach.
ExploreCONSULTING
Strategic hit discovery, target selection, workflow, and more.
ExploreDISCOVERY ON DEMAND
Build your lab with trusted experts.
ExploreLEAD OPTIMIZATION
Turning strong binders into superior candidates.
ExploreSCREENING
Peptide screening for lead sorting and identification.
ExploreEXPLORING THE MOMENTS THAT SPARK NEW POSSIBILITIES
Improving Pharmacokinetics of Peptides Using Phage Display
Optimization of the desired pharmacokinetic properties should be an important consideration in biopanning strategies to enable the selection of peptides and peptide-conjugated nanoparticles that effectively target biomarkers in vivo.
Best Practices in Phage Display: Optimizing Binding Affinity
Optimization of the desired pharmacokinetic properties should be an important consideration in biopanning strategies to enable the selection of peptides and peptide-conjugated nanoparticles that effectively target biomarkers in vivo.
Best Practices in Phage Display: Looking Beyond Binding Affinity
The true challenge of peptide discovery often lies beyond the basics of achieving high binding affinity — success depends on carefully managing key parameters such as off-target binding, biodistribution, and pharmacokinetics.
Radiopharmaceuticals: The Road Ahead
Radiopharmaceuticals are heralding a transformative era in cancer therapy, leveraging innovative approaches to target tumor cells with remarkable precision. Yet, as with any groundbreaking technology, the path to widespread implementation presents both immense opportunities and notable challenges.